February 22, 2022

Novavax’s COVID-19 vaccine approved for Canadians 18 and older

Novavax's COVID-19 vaccine has been approved for use in Canadians age 18 and older by Health Canada.

The approval of the vaccine, known as Nuvaxovid, comes about 18 months after the federal government announced a deal to produce batches of it in Montreal. Find out more here.